Patients & Visitors ›

Profile

Profile
Research

Peter E. Morris, M.D.

Professor, Pulmonary, Critical Care, Allergy, and Immunologic Medicine
Sticht Center on Aging

Clinical Specialties

Acute Respiratory Distress Syndrome (ARDS), Shock, Lung Injury, Pneumonia, Sepsis, Critical Care

Contact Information

Department: 336-716-2011

Insurance Accepted »

Education & Training

M.D., , 1985
B.S., Saint John's University , 1981
Internship, Medicine, Vanderbilt University School of Medicine, 1986
Residency, Vanderbilt Univ Medical Center, 1988
Fellowship, Pulmonary Disease, Vanderbilt University School of Medicine, 1991

NPI Number

1083699102

Peter E. Morris, M.D.

Professor, Pulmonary, Critical Care, Allergy, and Immunologic Medicine Sticht Center on Aging

Research Interests

critical/intensive care medici, drugs/therapeutic agents pharm, health services, research/outc, surgery/trauma/burns/trauma

Contact Information

Academic: 336-716-4325 | Department: 336-716-2011

Recent Publications

Cartwright MS, Kwayisi G, Griffin LP, Sarwal A, Walker FO, Harris JM, Berry MJ, Chahal PS, Morris PE. Quantitative neuromuscular ultrasound in the intensive care unit. Muscle Nerve. 2013;47(2):255-259.

Freeman BD, Morris PE. The ideal timing of tracheostomy remains uncertain [reply to letter]. Crit Care Med. 2013;41(3):e31.

Guntupalli K, Dean N, Morris PE, Bandi V, Margolis B, Rivers E, Levy M, Lodato RF, Ismail PM, Reese A, Schaumberg JP, Malik R, Dellinger RP. A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis. Crit Care Med. 2013;41(3):706-716.

Morris PE. Does U.S. health care need a national institute of critical care? [editorial]. Crit Care Med. 2012;40(4):1337-1338.

Calfee CS, Gallagher D, Abbott J, Thompson BT, Matthay MA, Hite RD, Morris P, Howard A, Nesser A, Perez S, et al. Plasma angiopoietin-2 in clinical acute lung injury: prognostic and pathogenetic significance. Crit Care Med. 2012;40(6):1731-1737.

Seeds MC, Grier BL, Suckling BN, Safta AM, Long DL, Waite BM, Morris PE, Hite RD. Secretory phospholipase A2-mediated depletion of phosphatidylglycerol in early acute respiratory distress syndrome. Am J Med Sci. 2012;343(6):446-451.

Morris PE, Zeno B, Bernard AC, Huang X, Das S, Edeki T, Simonson SG, Bernard GR. A placebo-controlled, double-blind, dose-escalation study to assess the safety, tolerability and pharmacokinetics/pharmacodynamics of single and multiple intravenous infusions of AZD9773 in patients with severe sepsis and septic shock. Crit Care. 2012;16(1):R31.

Freeman BD, Morris PE. Tracheostomy practice in adults with acute respiratory failure. Crit Care Med. 2012;40(10):2890-2896.

Kelley S, Agarwal S, Parikh N, Erslon M, Morris P. Development of postoperative pulmonary complications after admission to general care floor in elective surgery cases [abstract]. Crit Care Med. 2012;40(12 Suppl):743.

Kelley S, Agarwal S, Parikh N, Erslon M, Morris P. Respiratory insufficiency, arrest and failure among medical patients on the general care floor [abstract]. Crit Care Med. 2012;40(12 Suppl):764.

Kelley S, Agarwal S, Parikh N, Erslon M, Morris P. US hospital cost vs Medicare payment by ventilation status [abstract]. Crit Care Med. 2012;40(12 Suppl):713.

Morris PE, Steingrub JS, Huang BY, Tang S, Liu PM, Rhode PR, Wong HC. A phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndrome. BMC Pulm Med. 2012;12():5.

Morris P, Zeno B, Bernard A, Huang X, Simonson S, Bernard G. Safety and tolerability of an ovine-derived polyclonal anti-TNFalpha Fab fragment (AZD9773) in patients with severe sepsis [abstract]. Crit Care. 2011;15(Suppl 1):S93.

Morris PE, Griffin L, Berry M, Thompson C, Hite RD, Winkelman C, Ross A, Dixon L, Leach S, Haponik E, et al. Receiving early mobility during an intensive care unit admission is a predictor of improved outcomes in acute respiratory failure. Am J Med Sci. 2011;341(5):373-377.

Crawford J, Guntupalli KK, Dean NC, Morris PE, Malik RK, Schaunberg JP. Talactoferrin alfa (TLF) reduces mortality across a broad range of patients with severe sepsis [abstract]. J Thorac Oncol. 2011;6(6 Suppl 2):S1487.

Morris PE, Hildreth AN. High-dose vitamin D interventional trials: is there reason to pause? [editorial]. Minerva Anestesiol. 2011;77(12):1139-1140.

Hite RD, Seeds MC, Morris PE, Grier BL, Waite BM, Douglas IS, Hudson LD, Goodman RB. Regulation of secretory A2 phospholipase activity in persistent ARDS [abstract]. Am J Respir Crit Care Med. 2010;181():A6474.

Ross AG, Morris PE. Safety and barriers to care. Crit Care Nurse. 2010;30(2 Suppl):S11-S13.

Guntupalli KK, Dean NC, Morris PE, Bandi V, Margolis BD, Rivers E, Levy MM, Lodato RF, Schaumberg J, Malik RK, et al. Talactoferrin alfa reduces mortality in severe sepsis: results of a phase 2 randomized, placebo-controlled, double-blind study [abstract]. Am J Respir Crit Care Med. 2010;181(1 Meeting Abstracts):A6768.

Morris PE, Promes JT, Guntupalli KK, Wright PE, Arons MM. A multi-center, randomized, double-blind, parallel, placebo-controlled trial to evaluate the efficacy, safety, and pharmacokinetics of intravenous ibuprofen for the treatment of fever in critically ill and non-critically ill adults. Crit Care. 2010;14(3):R125.

Lanspa M, Brown S, Grissom C, Morris P, Malik R, Pittman J, Dean N. Talactoferrin may confer increased survival in patients with septic shock and systolic cardiac dysfunction [abstract]. Crit Care Med. 2010;38(12 Suppl):Abstr 757.

Levy M, Guntupalli K, Dellinger R, Dean N, Morris P, Bandi V, Margolis B, Rivers E, Lodato R, Schaumberg J. Talactoferrin alfa reduces 3 and 6 month all-cause mortality in patients with severe sepsis [abstract]. Crit Care Med. 2010;38(12 Suppl):abstr 26.

Morris PE. Assessing ICU transfers at night: a call to reduce mortality and readmission risk [editorial]. Am J Crit Care. 2009;18(1):6-8.

Morris PE. Time for critical care to join the CDC's universal HIV screening initiative? [editorial]. Am J Crit Care. 2009;18(2):96-99.

Morris PE, Munro CL. All ICUs are not created equal: evaluating pilot studies performed in different environments [editorial]. Am J Crit Care. 2009;18(4):294-297.

Munro CL, Morris PE. Seasonal influenza: protect your patients by protecting yourself [editorial]. Am J Crit Care. 2009;18(5):396-398.

Morris PE, Munro CL. Will comparative effectiveness research increase patient safety in intensive care units? [editorial]. Am J Crit Care. 2009;18(6):504-506.

Morris PE, Papadakos P, Russell JA, Wunderink R, Schuster DP, Truwit JD, Vincent J-L, Bernard GR. A double-blind placebo-controlled study to evaluate the safety and efficacy of L-2-oxothiazolidine-4-carboxylic acid in the treatment of patients with acute respiratory distress syndrome. Crit Care Med. 2008;36(3):782-788.

Morris PE, Goad A, Thompson C, Taylor K, Harry B, Passmore L, Ross A, Howard A, Hite RD, Haponik E, et al. Early intensive care unit mobility therapy in the treatment of acute respiratory failure. Crit Care Med. 2008;36(8):2238-2243.

Morris PE, Dracup K. Could multicenter trials optimize the cost of prolonged mechanical ventilation? [editorial]. Am J Crit Care. 2008;17(1):8-10.

Dracup K, Morris PE. How will they learn? [editorial]. Am J Crit Care. 2008;17(4):306-309.

Dracup K, Morris PE. Passing the torch: the challenge of handoffs [editorial]. Am J Crit Care. 2008;17(2):95-97.

Morris PE, Dracup K. Foundations of evidence-based practice: critical care trial networks [editorial]. Am J Crit Care. 2008;17(3):190-193.

Morris PE, Dracup K. Time for a tool to measure moral distress? [editorial]. Am J Crit Care. 2008;17(5):398-401.

Morris PE. Preface. Crit Care Clin. 2007;23(1):ix-xi.

Morris PE. Moving our critically ill patients: mobility barriers and benefits. Crit Care Clin. 2007;23(1):1-20.

Morris PE, Herridge MS. Early intensive care unit mobility: future directions. Crit Care Clin. 2007;23(1):97-110.

Morris PE. Critical care professionalism in the age of pay-for-performance: from ICUs to outpatient critical care clinics [editorial]. Am J Crit Care. 2007;16(3):200-203.

Updaw R, Passmore L, Mitten-Long D, Pierce C, Ross A, Wells G, Morris P. Fluid resuscitation volume for septic shock patients was not decreased for echocardiogram-determined left ventricular (LV) systolic dysfunction patients when managed with early goal-directed therapy (EGDT) [abstract]. Chest. 2007;132(4 Suppl):495S.

Dracup K, Morris PE. Global poverty: a challenge for critical care [editorial]. Am J Crit Care. 2007;16(6):528-530.

Morris PE, Dracup K. Quality improvement or research? The ethics of hospital project oversight [editorial]. Am J Crit Care. 2007;16(5):424-426.

Rice TW, Wheeler AP, Morris PE, Paz HL, Russell JA, Edens TR, Bernard GR. Safety and efficacy of affinity-purified, anti-tumor necrosis factor-alpha, ovine fab for injection (CytoFab) in severe sepsis. Crit Care Med. 2006;34(9):2271-2281.

Daniel A, Owen S, Ross A, Brown J, Ashley A, Bozeman W, Karchmer T, Williamson J, Passmore L, Morris PE, et al. A multi-department strategy for severe sepsis patient resuscitation [abstract]. Crit Care Med. 2006;34(12 Abstr Suppl):A143.

Morris PE, Holbrook A, Thompson C, Ross A, Anderson L, Baker S, Penley L, Daniel A, Howard A, Passmore L, et al. A mobility protocol for acute respiratory failure patients delivered by an ICU mobility team shortens hospital stay [abstract]. Crit Care Med. 2006;34(12 Abstr Suppl):A20.